A Randomized Trial of Nafamostat for Covid-19.

Morpeth SC, Venkatesh B, Totterdell JA, McPhee GM, Mahar RK, Jones M, Bandara M, Barina LA, Basnet BK, Bowen AC, Burke AJ, Cochrane B, Denholm JT, Dhungana A, Dore GJ, Dotel R, Duffy E, Dummer J, Foo H, Gilbey TL, Hammond NE, Hudson BJ, Jha V, Jevaji PR, John O, Joshi R, Kang G, Kaur B, Kim S, Das SK, Lau JSY, Littleford R, Marsh JA, Marschner IC, Matthews G, Maze MJ, McArthur CJ, McFadyen JD, McMahon JH, McQuilten ZK, Molton J, Mora JM, Mudaliar V, Nguyen V, O'Sullivan MVN, Pant S, Park JE, Paterson DL, Price DJ, Raymond N, Rees MA, Robinson JO, Rogers BA, Ryu WS, Sasadeusz J, Shum O, Snelling TL, Sommerville C, Trask N, Lewin SR, Hills TE, Davis JS, Roberts JA, Tong SYC

Open source

DOI
10.1056/evidoa2300132
Published
2023 Nov
Container
NEJM evidence
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1056/evidoa2300132,
  title = {A Randomized Trial of Nafamostat for Covid-19.},
  author = {Morpeth SC and Venkatesh B and Totterdell JA and McPhee GM and Mahar RK and Jones M and Bandara M and Barina LA and Basnet BK and Bowen AC and Burke AJ and Cochrane B and Denholm JT and Dhungana A and Dore GJ and Dotel R and Duffy E and Dummer J and Foo H and Gilbey TL and Hammond NE and Hudson BJ and Jha V and Jevaji PR and John O and Joshi R and Kang G and Kaur B and Kim S and Das SK and Lau JSY and Littleford R and Marsh JA and Marschner IC and Matthews G and Maze MJ and McArthur CJ and McFadyen JD and McMahon JH and McQuilten ZK and Molton J and Mora JM and Mudaliar V and Nguyen V and O'Sullivan MVN and Pant S and Park JE and Paterson DL and Price DJ and Raymond N and Rees MA and Robinson JO and Rogers BA and Ryu WS and Sasadeusz J and Shum O and Snelling TL and Sommerville C and Trask N and Lewin SR and Hills TE and Davis JS and Roberts JA and Tong SYC},
  year = {2023},
  journal = {NEJM evidence},
  doi = {10.1056/evidoa2300132},
  url = {https://doi.org/10.1056/evidoa2300132}
}

RIS

TY  - JOUR
TI  - A Randomized Trial of Nafamostat for Covid-19.
AU  - Morpeth SC
AU  - Venkatesh B
AU  - Totterdell JA
AU  - McPhee GM
AU  - Mahar RK
AU  - Jones M
AU  - Bandara M
AU  - Barina LA
AU  - Basnet BK
AU  - Bowen AC
AU  - Burke AJ
AU  - Cochrane B
AU  - Denholm JT
AU  - Dhungana A
AU  - Dore GJ
AU  - Dotel R
AU  - Duffy E
AU  - Dummer J
AU  - Foo H
AU  - Gilbey TL
AU  - Hammond NE
AU  - Hudson BJ
AU  - Jha V
AU  - Jevaji PR
AU  - John O
AU  - Joshi R
AU  - Kang G
AU  - Kaur B
AU  - Kim S
AU  - Das SK
AU  - Lau JSY
AU  - Littleford R
AU  - Marsh JA
AU  - Marschner IC
AU  - Matthews G
AU  - Maze MJ
AU  - McArthur CJ
AU  - McFadyen JD
AU  - McMahon JH
AU  - McQuilten ZK
AU  - Molton J
AU  - Mora JM
AU  - Mudaliar V
AU  - Nguyen V
AU  - O'Sullivan MVN
AU  - Pant S
AU  - Park JE
AU  - Paterson DL
AU  - Price DJ
AU  - Raymond N
AU  - Rees MA
AU  - Robinson JO
AU  - Rogers BA
AU  - Ryu WS
AU  - Sasadeusz J
AU  - Shum O
AU  - Snelling TL
AU  - Sommerville C
AU  - Trask N
AU  - Lewin SR
AU  - Hills TE
AU  - Davis JS
AU  - Roberts JA
AU  - Tong SYC
PY  - 2023
JO  - NEJM evidence
DO  - 10.1056/evidoa2300132
UR  - https://doi.org/10.1056/evidoa2300132
ER  -

APA

SC, M., B, V., JA, T., GM, M., RK, M., M, J., M, B., LA, B., BK, B., AC, B., AJ, B., B, C., JT, D., A, D., GJ, D., R, D., E, D., J, D., H, F., TL, G., NE, H., BJ, H., V, J., PR, J., O, J., R, J., G, K., B, K., S, K., SK, D., JSY, L., R, L., JA, M., IC, M., G, M., MJ, M., CJ, M., JD, M., JH, M., ZK, M., J, M., JM, M., V, M., V, N., MVN, O., S, P., JE, P., DL, P., DJ, P., N, R., MA, R., JO, R., BA, R., WS, R., J, S., O, S., TL, S., C, S., N, T., SR, L., TE, H., JS, D., JA, R., & SYC, T. (2023). A Randomized Trial of Nafamostat for Covid-19.. NEJM evidence. https://doi.org/10.1056/evidoa2300132

Source records